An Audit of Systemic Therapy in Medullary Carcinoma Thyroid.

导出 OA

翻译打印收藏纠错

第一作者： Aditya Pavan Kumar,Kanteti

第一单位： Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai 400012 India.

作者： Aditya Pavan Kumar,Kanteti ^[1] ; George,Abraham ^[1] ; Vijay M,Patil ^[1] ; Nandini,Menon ^[1] ; Tanmoy,Mandal ^[1] ; Sobin V,Jacob ^[1] ; Keshav,Garg ^[1] ; Anbarasan,Sekar ^[1] ; Rup Jyoti,Sarma ^[1] ; Laxma Reddy,Mekala ^[1] ; Dipti,Nakti ^[1] ; Neha,Mittal ^[2] ; Munita,Bal ^[2] ; Swapnil,Rane ^[2] ; Nilendu C,Purandare ^[3] ; Abhishek,Mahajan ^[4] ; Nilesh,Sable ^[4] ; Suman,Kumar ^[4] ; Vanita,Noronha ^[1] ; Kumar,Prabhash ^[1]

作者单位： Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai 400012 India. ^[1] Department of Pathology, Tata Memorial Hospital, Mumbai, India. ^[2] Department of Nuclear Medicine, Tata Memorial Hospital, Mumbai, India. ^[3] Department of Radiology, Tata Memorial Hospital, Mumbai, India. ^[4]

关键词 Immediate Medullary thyroid cancer Sorafenib Symptomatic Tyrosine kinase inhibitor (TKI)

DOI 10.1007/s13193-021-01381-x

PMID 35462671

发布时间 2023-03-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交